Keyphrases
Mesenchymal Stem Cells
88%
Systemic Lupus Erythematosus
30%
T Helper 17 (Th17)
26%
T Cells
21%
Human Mesenchymal Stem Cells (hMSCs)
18%
Rheumatic Fever
18%
Cell Therapy
15%
Rheumatic Heart Disease
15%
Systemic Lupus Erythematosus Patient
14%
Endometrial Stem Cells
14%
Mesenchymal Stromal Cells
14%
Experimental Autoimmune Encephalomyelitis
14%
Valvular
14%
Interleukin-17 (IL-17)
14%
Rat Model
13%
Chronic Kidney Disease
13%
Mesenchymal Stem Cell Therapy
13%
Connective Tissue Disease
13%
Disease Activity
12%
Th1 Cells
11%
Autoimmune Disease
11%
Heart Failure Patients
11%
Stem Cell Therapy
10%
Stem Cells
9%
Antiphospholipid Syndrome
9%
Toll-like
9%
Human Umbilical Cord Mesenchymal Stromal Cells
9%
Mitochondrial Transfer
9%
Group A Streptococcus
8%
Tissue Damage
8%
Lymphocytes
8%
Regulatory T (Treg) Cells
8%
Anticardiolipin Antibodies
7%
Phase II Trial
7%
Interleukin-6
7%
Rheumatoid Arthritis
7%
Cell-based
7%
Intravenous Infusion
6%
Fever Patient
6%
Immunosuppressive Properties
6%
CD4+CD25+Foxp3+
6%
Stem Cell-derived
6%
Inflammatory Response
6%
Transplantation
6%
Immunosuppression
6%
Differentiation Potential
6%
Clinical Diagnosis
6%
Bromocriptine
6%
Autologous Mesenchymal Stem Cells
6%
Cellular Immune Response
6%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Systemic Lupus Erythematosus
32%
Immunosuppressive Drug
26%
T Cell
23%
Regulatory T Cell
19%
Th17 Cell
18%
Experimental Autoimmune Encephalomyelitis
15%
Rat Model
13%
Stem Cell
13%
Autoimmune Disease
13%
Bone Marrow Derived Mesenchymal Stem Cell
12%
Th1 Cell
12%
CD4
11%
Interleukin 6
10%
Immunity
10%
Cytokine
10%
Lupus Erythematosus
10%
Inflammatory Arthritis
9%
T-Helper Cell
9%
Arthritis
9%
Connective Tissue
9%
Rheumatic Heart Disease
9%
CD25
7%
Cytotoxic T-Cell
7%
Cell Population
7%
Inflammation Response
6%
Umbilical Cord
6%
T Cell Activation
6%
Graft-Versus-Host Disease
6%
Immune System
5%
Toll-Like Receptor
5%
Stem Cell Transplantation
5%
Streptococcus Group A
5%
Medicine and Dentistry
Mesenchymal Stem Cell
49%
Systemic Lupus Erythematosus
30%
Rheumatic Fever
17%
T Cell
17%
Stem Cell
17%
Rheumatic Heart Disease
14%
Disease
13%
Cell Therapy
13%
Bone Marrow Derived Mesenchymal Stem Cell
12%
Infection
11%
Umbilical Cord
10%
Antiphospholipid Syndrome
9%
Receptor
9%
Immunosuppressive Drug
8%
Antigen Specificity
8%
Streptococcus Group A
7%
Cardiovascular Disease
7%
Cardiolipin Antibody
7%
In Vitro
7%
Congestive Heart Failure
7%
Autoimmune Disease
6%
Quality of Life
6%
Cardiovascular System
6%
Lupus Erythematosus
6%
Randomized Clinical Trial
5%
Stem Cell Therapy
5%
Programmed Cell Death
5%
Lymphocyte
5%
Experimental Autoimmune Encephalomyelitis
5%
microRNA
5%
Stromal Cell
5%
Cytotoxic T-Cell
5%
Intravenous Drug Administration
5%
Immunity
5%
Carditis
5%
Disease Activity
5%
Th17 Cell
5%
Antiphospholipid Antibody
5%
